For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of this treatment and Attruby represents a significant breakthrough . These novel therapies https://pbm760674.mybjjblog.com/major-attr-cm-development-vyndamax-and-attruby-offer-hope-54313354